During the past decade, Arena Pharmaceuticals, Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Arena Pharmaceuticals, Inc." are "Obesity" (3 trials) and "Primary Insomnia" (1 trials). Many other conditions were trialed in "Arena Pharmaceuticals, Inc." in a lesser frequency.

Most popular intervention types in "Arena Pharmaceuticals, Inc." are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Lorcaserin 10 mg once daily (QD)" (2 trials), "Lorcaserin 10 mg twice a day (BID)" (2 trials), "Matching Placebo" (2 trials), "APD125" (1 trials) and "Lorcaserin 10 mg BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arena Pharmaceuticals, Inc." are 4 trials for "All" genders.

Currently, there are NaN active trials in "Arena Pharmaceuticals, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Arena Pharmaceuticals, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arena Pharmaceuticals, Inc., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".